Infections as causative factors of epilepsy

• Eriksson KJ , KoivikkoMJ: Prevalence, classification, and severity of epilepsy and epileptic syndrome in children.Epilepsia38, 1275–1282 (1997).
   PubMed Web of Science ®Google Scholar
• Fujiwara T , ShigematsuH: Etiologic factors and clinical features of symptomatic epilepsy: focus on pediatric cases.Psychiatry Clin. Neurosci.58, S9–S12 (2004).
   PubMed Web of Science ®Google Scholar
• Yamashita N , MorishimaT: HHV-6 and seizures.Herpes12, 46–49 (2005).
   PubMedGoogle Scholar
• Chan PK , NgHK, HuiM, ChengAF: Prevalence and distribution of human herpes virus 6 variants A and B in adult human brain.J. Med. Virol.64, 42–46 (2001).
   PubMed Web of Science ®Google Scholar
• Donati D , AkhyaniN, Fogdell-HahnAet al.: Detection of human herpes virus-6 in mesial temporal lobe epilepsy surgical brain resections.Neurology25, 1405–1411 (2003).
   Google Scholar
• Oguni H , AndermannF, RasmussenTB: The natural history of the syndrome of chronic encephalitis and epilepsy: a study of the MNI series of forty-eight cases. In: Chronic Encephalitis and Epilepsy. Rasmussen's Syndrome. Andermann F (Ed.). Butterworth–Heinemann, MA, USA, 7–35 (1991).
   Google Scholar
• Bien CG , WidmanG, UrbachHet al.: The natural history of Rasmussen‘s encephalitis. Brain125, 1751–1759 (2002).
   PubMed Web of Science ®Google Scholar
• Aguilar MJ , RasmussenT: Role of encephalitis in pathogenesis of epilepsy. AMA Arch. Neurol.2, 663–676 (1960).
   PubMedGoogle Scholar
• Farrell MA , DrooganO, SecorDL, Poukens V, Quinn B, Vinters HV: Chronic encephalitis associated with epilepsy: immunohistochemical and ultrastructural studies. Acta Neuropathol.89, 313–321 (1995).
   PubMed Web of Science ®Google Scholar
• Rogers SW , AndrewsPI, GahringLCet al.: Autoantibodies to glutamate receptor GluR3 in Rasmussen‘s encephalitis.Science265, 648–651 (1994).
   PubMed Web of Science ®Google Scholar
• Bien CG , BauerJ, DeckwerthTLet al.: Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen‘s encephalitis.Ann. Neurol.51, 311–318 (2002).
   PubMed Web of Science ®Google Scholar
• Takahashi Y , MoriH, MishinaMet al.: Autoantibodies to NMDA receptor in patients with chronic forms of epilepsia partialis continua.Neurology61, 891–896 (2003).
   PubMed Web of Science ®Google Scholar
• Takahashi Y , MoriH, MishinaMet al.: Autoantibodies and cell-mediated autoimmunity to NMDA-type GluRε2 in patients with Rasmussen‘s encephalitis and chronic progressive epilepsia partialis continua.Epilepsia46(Suppl. 5), 152–158 (2005).
   PubMedGoogle Scholar
• Camfield P , CamfielC, KurlemannGet al.: Febrile seizures. In:Epileptic Syndrome in Infancy, Childhood, and Adolescence. Roger J, Bureau M, Dravet C et al. (Eds). John Libbey, London, UK, 145–152 (2002).
   Google Scholar
• French JA , WilliamsonPD, ThadaniVMet al.: Characteristics of mesial temporal lobe epilepsy: I. Results of history and physical examination. Ann. Neurol.34, 774–780 (1993).
   PubMed Web of Science ®Google Scholar
• Cendes F , KahaneP, BrodieM, Andermann F: The mesio-temporal lobe epilepsy syndrome. In: Epileptic Syndrome in Infancy, Childhood, and Adolescence.RogerJ, BureauM, DravetCet al. (Eds). John Libbey, London, UK, 513–530 (2002).
   Google Scholar
• Chen K , BaranTZ, SolteszI: Febrile seizures in the developing brain of rats result in persistent modification of neuronal excitability in limbic circuits.Nature Med.5, 888–894 (1999).
   PubMed Web of Science ®Google Scholar
• Gardiner M : Genetics of idiopathic generalized epilepsies.Epilepsia46(Suppl. 9), 15–20 (2005).
   PubMedGoogle Scholar
• Fujiwara T , SugawaraT, Mazaki-Miyazaki Eet al.: Mutations of sodium channel α subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized tonic-clonic seizures. Brain126, 531–546 (2003).
   PubMed Web of Science ®Google Scholar
• Kanai K , HiroseS, OguniHet al.: Effect of localization of missense mutations in SCN1A on epilepsy phenotype severity. Neurology63, 329–334 (2004).
   PubMed Web of Science ®Google Scholar
• Davis RL , BarlowW: Placing the risk of seizures with pediatric vaccines in a clinical context.Paediatr. Drugs5, 717–722 (2003).
   PubMedGoogle Scholar
• McMahon AW , IskanderJ, HaberPet al.: Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990–2003. Pediatrics115, 453–460 (2005).
   PubMed Web of Science ®Google Scholar
• Sejvar J , LabuttaRJ, ChapmanLEet al.: Neurologic adverse events associated with smallpox vaccination in the United States, 2002–2004. JAMA294, 2744–2750 (2005).
   PubMed Web of Science ®Google Scholar
• Takahashi Y , MatsudaY, KubotaYet al.: Vaccination and infection as causative factors in Japanese patients with Rasmussen syndrome: Molecular mimicry and HLA class I. Clin. Dev. Immunol. (2006) In press.
   PubMedGoogle Scholar
• Korn A , GolanH, MelamedI, Pascual-MarquiR, FriedmanAJ: Focal cortical dysfunction and blood–brain barrier disruption in patients with postconcussion syndrome.Clin. Neurophysiol.22, 1–9 (2005).
   Web of Science ®Google Scholar
• Li Y , UccelliA, LaxerKDet al.: Local-clonal expansion of infiltrating T lymphocytes in chronic encephalitis of Rasmussen. J. Immunol.158, 1428–1437 (1997).
   PubMed Web of Science ®Google Scholar
• Roubertie A , BoukhaddaouiH, SiesoVet al.: Antiglial cell autoantibodies and childhood epilepsy: a case report. Epilepsia46, 1308–1312 (2005).
   PubMedGoogle Scholar
• Bien CG , GleissnerU, SassenRet al.: An open study of tacrolimus therapy in Rasmussen encephalitis. Neurology62, 2106–2109 (2004).
   PubMed Web of Science ®Google Scholar
• Levite M , HermelinA: Autoimmunity to the glutamate receptor in mice – a model for Rasmussen‘s encephalitis?J. Autoimmun.13, 73–82 (1999).
   PubMed Web of Science ®Google Scholar
• He XP , PatelM, WhitneyKD, Janumpalli S, Tenner A, McNamara JO: Glutamate receptor GluR3 antibodies and death of cortical cells. Neuron20, 153–163 (1998).
   PubMed Web of Science ®Google Scholar
• Xiong ZO , McNamaraJO: Fleeting activation of ionotropic glutamate receptors sensitizes cortical neurons to complement attack.Neuron36, 363–374 (2002).
   PubMed Web of Science ®Google Scholar
• Xiong ZO , QianW, SuzukiK, McNamara JO: Formation of complement membrane attack complex in mammalian cerebral cortex evokes seizures and neurodegeneration. J. Neurosci.23, 955–960 (2003).
   PubMed Web of Science ®Google Scholar
• Twyman RE , GahringLC, SpiessJ, Rogers SW: Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site. Neuron14, 755–762 (1995).
   PubMed Web of Science ®Google Scholar
• Uemura Y , SenjuS, MaenakaKet al.: Systematic analysis of the combinatorial nature of epitopes recognized by TCR leads to identification of mimicry epitopes for glutamic acid decarboxylase 65-specific TCRs. J. Immunol.170, 947–960 (2003).
   PubMed Web of Science ®Google Scholar
• Takahashi Y : Immunological aspects in epileptogenesis.Epilepsia46(Suppl. 3), 6–7 (2005).
   Google Scholar
• Wiendl H , BienCG, BernasconiPet al.: GluR3B antibodies: prevalence in focal epilepsy but no specificity for Rasmussen‘s encephalitis. Neurology57, 1511–1514 (2001).
   PubMed Web of Science ®Google Scholar
• Watson R , JiangY, BermudezIet al.: Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis. Neurology63, 43–50 (2004).
   PubMed Web of Science ®Google Scholar
• Vezzani A , GranataT: Brain inflammation in epilepsy: experimental and clinical evidence.Epilepsia46, 1724–1743 (2005).
   PubMed Web of Science ®Google Scholar
• Nishimura Y , ChenYZ, UemuraYet al.: Degenerate recognition and response of human CD4+ Th cell clones: implication for basic and applied immunology. Mol. Immunol.40, 1089–1094 (2004).
   PubMed Web of Science ®Google Scholar

Websites

• Ministery of Health, Labor and Welfare (Japanese site) www.mhlw.go.jp/shingi/2004/09/dl/s0924-4c.pdf
   Google Scholar
• Genome Net www.genome.jp
   Google Scholar